"A world-wide prospective study of INC on prognosis and biomarkers in GBS"

A world-wide prospective study of INC on prognosis and biomarkers in GBS

Current number of inclusions:

IGOS 1500 inclusions!

Congratulations to you all, and especially to Dr. Wang from the Affiliated Hospital of Jining in China! We reached inclusion number 1500!

Recruitment is still open, we will inform you of the future of IGOS shortly. Colleagues in the USA, you have already received an update regarding recruitment in the USA.

Thank you all for this tremendous support and we hope to see many of you during the PNS congress in Sitges, Spain.

The IGOS Coordinating CentreMore >>
More news

International Guillain-Barré syndrome outcome study (IGOS)



Welcome to the website for the International Guillain-Barré syndrome Outcome Study (IGOS). The study aims to identify clinical and biological determinants and predictors of disease course in Guillain-Barré syndrome. The study is conducted by the Inflammatory Neuropathy Consortium (INC). At this website you can acquire information about IGOS, register as IGOS participant and include patients with Guillain-Barré syndrome. For more information about IGOS, click here.